Sign in

Bernard A. Fox

@bernardafox.bsky.social
2.1K followers 3.9K following 189 posts

Cancer Immunotherapy & Harder Family Chair Cancer Research #FoxLab @ChilesResearch /CEO @UbiVac / @OHSUmmi.bsky.social /exPres&Ambassador @SITCancer.bsky.social /ex #NCI /ex #Detroit /M GO BLUE/ WIC & JEDI/ @detroitlions.bsky.social /❤️Pinot/Tweets my own

PostsRepliesMedia
Bernard A. Fox @bernardafox.bsky.social · 24/12/2025
Dr. @ertrunnell.bsky.social thanks for posting. While there is much yet to do, think in not too distant future #GigaTIME will have a major impact in tailoring therapies to patients with #cancer #GSK #Astrazeneca #Regeneron #Abbvie #incyte #FDA #NCI #FinishCancer
051
Bernard A. Fox @bernardafox.bsky.social · 08/11/2025
Dr. Wim Vos CEO #Radiomics_Bio opens session on Imaging, radionics, and integrated biomarkers at #SITC2025 / important topic that holds promise to predict response and accelerate treatment decisions for patients with cancer #Radiomics
083
Reposted by Bernard A. Fox
Society for Immunotherapy of Cancer @sitcancer.bsky.social · 03/11/2025
4 decades of IO – Celebrating 40 years of SITC. In 2020, our membership surpassed 4,000 members as we launched two programs: the Certificate in Cancer Immunotherapy and Global Access to Immunotherapy. Our Annual Meeting was held fully virtual due to the COVID-19 pandemic.
031
Bernard A. Fox @bernardafox.bsky.social · 07/11/2025
@heinimnatri.bsky.social WELCOME TO #SITC2025 - Hope you find attendance rewarding! @sitcancer.bsky.social
040
Reposted by Bernard A. Fox
Society for Immunotherapy of Cancer @sitcancer.bsky.social · 06/11/2025
4 decades of IO – Celebrating 40 years of SITC. In 2024, we published “Challenges and opportunities in cancer immunotherapy: a SITC strategic vision”. We also announced a vision for 100 novel IO agents to be approved by 2034 with IO Drug Development Summit in Boston, MA
011
Reposted by Bernard A. Fox
Society for Immunotherapy of Cancer @sitcancer.bsky.social · 06/11/2025
Our 2025 Workshop, “Leveraging the Power of Artificial Intelligence to Foster Progress in Immuno-oncology..." educated the IO community to develop new cancer immunotherapies and improve patient care with AI. @jasmineplummer.bsky.social @aruthak.bsky.social @fertiglab.bsky.social @dinler.bsky.social
073
Bernard A. Fox @bernardafox.bsky.social · 07/11/2025
Wonderful recognition of Dr. Marc Theoret by #SITC at #SITC2025 Who during 16 years at FDA worked to bridge the scientific and regulatory communities to support bench-to-bedside clinical trials accelerating delivery of novel immunotherapies to patients with #cancer
020
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr Regina Hoo from National Cancer Center Singapore / DukeNUS - tracking adaption and response to therapy in EGFR-mutant #NSCLC. CD39 hi cells & Tregs are enriched in Tx naive pts - TKI Tx reduces exhaustion status/ Tumor-MAC crosstalk/ ALL SLIDES “DO NOT POST” #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Guannan Kang @ Chinese University of Hong Kong representing #HongKong #Cancer #Therapy Society ( #HKCTS ) talks #Fragmentomis for plasma #EBV detection & #NPC development. #FRAGMA #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Guannan Kang @ Chinese University of Hong Kong representing #HongKong #Cancer #Therapy Society ( #HKCTS ) talks #Fragmentomis for plasma #EBV detection & #NPC development. #FRAGMA #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr Kailyn FEI from #Chinese #Academy of #Medical #Sciences ( #CAMS )representing #Chinese society #Clinical #Oncology ( #CSCO ) looks at role for chemo #immunotherapy in rare mutant #NSCLC / #BRAF #ROS1 #RET / lots unpublished - not posted - data / #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr Beung Chul Ahn @ Center for #LungCancer, #National #Cancer #Institute #Korea / Korean Society for Medical Oncology #KSMO / talks on treatment for lung cancer/ biomarkers to assess patients most likely to benefit from neoadjuvant / adjuvant therapy #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Yuan Wang from Univ #Halle & Brandenburg, Germany representing #Tumor #Immunology Meets #Oncology / #TIMO - Talks on class I antigen presentation. Role of miR in regulating tapasin & HLA. Plus TAMs, CXCR3 RBP. #DKFZ #WIC2025 #SITC2025 #Sachsen_Anhalt
021
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Chen-Yang Huang from Linkou Chang Gang Memorial Hospital, Taiwan representing Taiwan Soc for Immunotherapy of Cancer #TSITC/ Talks on #anticancer effects of #CPG induced neutrophils & clonal expansion of T cells/. #WIC2025 #SITC2025
020
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Puritan Luangwattananun from #Siriraj Hospital, #Mahidol University, #Thailand talks about a dual bispecific T cell engager approach to treat #BreastCancer #WIC2025 #SITC2025
020
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr Loubna Oumeslakht representing the #Moracan Society for #Immunology talked on #Sezary #Syndrome Cells/ kinetics of #ICOSligands & role of ICOS isoforms in disease and as a target for treatment. #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Yan Li from #USTC #Hefei #China talks on therapy for #Hepatocellular #Cancer / #HCC. #CXCR1 #nanobody approach to treat HCC & other cancer types. Focused on effects on NK cells. CXCL8 is the ligand. #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Catherine Phelps from @upmc.com representing #SITC Talks on how #exercise can improve outcome - role for #microbial #metabolite #formate on mediating #anticancer #immunity / #WIC2025 #SITC2025
162
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Jaime Fuentealba representing #French #Society for #Immunotherapy of #Cancer ( #FITC ) talks on #PCNLS #ocular #lymphoma & novel #SUV39H1 ko CAR T cell treatment approach - clinical trial in 2026 #WIC2025 #SITC2025
010
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Great panel discussion with speakers from the #WIC2025 #Tumor #Micro #Environment ( #TME ) session / chaired by Prof. Joe Yeong / Prof. Lotze notes possible role for early T cell infiltration into post-partum breast tissue #JITC #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr Pan Jia Wern representing #Malaysian Soc for #Biochemistry & #Molecular #Biology talks on #BreastCancer / role of parity, microbiome, & germline variants/ #APOBEC3B deletion has increased RR to anti-PD-1 #WIC2025 #SITC2025
130
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr Wenting Liu from #Fudan Univ. Representing #Chinese #Society for #Immunology ( #CSI ) & #Tumor Immunology & #Biological #Therapy ( #TIBT ) talks on Tu-specific PMNs / #scRNA HLA-DR+IGF1R+ TAN promote tu suppression #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Augusto Bleve representing #Italian #Network for #Tumor #Biotherapy ( #NIBIT ) talks on role of #hypercholesterolemia on #anticancer #immunity / #PCSK9 #RORgamma #WIC2025 #SITC2025
010
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Dr. Joao Scarini from #Brazil & representing #Latin #American & #Caribbean #Association For #Immunology evaluated differences between pts that recur & those that are disease free. TCR diversity - See conclusions. #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Peter Schol from #KWF #Dutch #Tumor #immunology Meeting (KWF-DTIM) presents on novel nanoparticle approach to eliminate CD163+ M2 like Macs. #WIC2025 #SITC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
Michael Geuenich PhD student representative from #Canadian #Cancer #Immunotherapy #Consortium (CCIC) talks on AI and Tertiary lymphoid structuctures in #pancreatic cancer. #SITC2025 #WIC2025
000
Bernard A. Fox @bernardafox.bsky.social · 05/11/2025
It has started #WIC2025 opened at #SITC2025 - Prof. Pamela Ohashi #Toronto made introductory remarks.
010
Reposted by Bernard A. Fox
OncoDaily @oncodaily.bsky.social · 17/10/2025
Cancer Vaccines and Combination Immunotherapy - Bernard A. Fox @bernardafox.bsky.social oncodaily.com/voices/cance... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #CancerVaccine
oncodaily.com
Bernard A. Fox: Cancer Vaccines and Combination Immunotherapy - OncoDaily
Bernard A. Fox: Cancer Vaccines and Combination Immunotherapy / Bernard A. Fox, cancer, cancer vaccines, OncoDaily, Oncology, Paolo A. Ascierto
071
Bernard A. Fox @bernardafox.bsky.social · 10/10/2025
Looking forward to being in #Amsterdam for Tara Muijlwijk thesis defense @vuamsterdam.bsky.social on 10/13. On 10/14 looking forward to visit the VU & seeing what my friend, colleague, & mentee, Prof. Rieneke van de Ven is up to. #immunotherapy #DarkMatter #cancer @sitcancer.bsky.social #HNSCC
031
Reposted by Bernard A. Fox
Raider @iwillnotbesilenced.bsky.social · 27/08/2025
This song remains incredibly relevant in 2025. Harold Melvin and the Blue Notes ft Teddy Pendergrass performing "wake up everybody"
16437871225
Reposted by Bernard A. Fox
Jake Scott, MD @jakescottmd.bsky.social · 24/08/2025
US RSV immunizations cut infant hospitalizations ~30–40% last season. Yet ACIP member Dr. Malone and Dr. Shir-Raz published a piece claiming CDC "manipulated data analyses" and hid deaths to get these therapies approved. Their claims fall apart under scrutiny. 🧵
314555
Reposted by Bernard A. Fox
EUMETSAT OSI SAF @osi-saf.eumetsat.int · 04/07/2025
🛰️New Product ! 🛰️ Our #SeaIce team at @met.no and @dmidk.bsky.social has been working hard to ensure you reliable and lasting access to sea ice concentration Climate Data Record. Today we release as demonstrational a new #AMSR-2 based Interim CDR (OSI-438) osi-saf.eumetsat.int/community/li...
OSI SAF Sea Ice Concentration ICDR from AMSR-2 (OSI-438) for the 18/06/2025 - Northern HemisphereOSI SAF Sea Ice Concentration ICDR from AMSR-2 (OSI-438) for the 18/06/2025 - Southern Hemisphere
0166
Reposted by Bernard A. Fox
Society for Immunotherapy of Cancer @sitcancer.bsky.social · 09/06/2025
#SITC25 Science Preview: Join @bernardafox.bsky.social, @klebanofflab.bsky.social, Rom S. Leidner, MD, Earle A. Chiles Research Institute, Catherine J. Wu, MD @danafarber.bsky.social to describe novel cancer antigens derived from the dark genome. Browse details: www.sitcancer.org/2025/schedul...
031
Bernard A. Fox @bernardafox.bsky.social · 04/06/2025
More #THERANOSTICS - Prof Richard Wahl #MalinckrodtInstitute #MIR gives a bit more history on the topic. 1st iodine-labelled #monoclonal #antibodies. #FDG #ASTRO2025 #FinishCancer @uwiscradiology.bsky.social
240
Bernard A. Fox @bernardafox.bsky.social · 04/06/2025
🧐???? #THERANOSTICS ???? Looking forward to hearing the first two keynotes at THERANOSTICS conference being held at the new #Discovery building at @uwiscradiology.bsky.social @uwiscpress.bsky.social #cancer #radiation #Therapy #ASTRO #FinishCancer #Pluvicto #Novartis #PCF #ProstateCancer
130
Bernard A. Fox @bernardafox.bsky.social · 25/05/2025
💥#TIMO2025 Great line-up of #immunotherapy experts/I talked #Cancer #antigens & #DarkGenome-derived #DarkMatter/ IMO: Recent studies explain why combination #immunotherapy with #personalized #neoantigen #vaccines are SUBOPTIMAL. See www.nature.com/articles/s43... www.science.org/doi/10.1126/...
140
Bernard A. Fox @bernardafox.bsky.social · 05/05/2025
Dr. Tyler Hulett from #CDI #puertoRico is wowing the crowd at #AAI2025 with methods to assay antibody responses in serum! They are making progress advancing the field with everything from Ab to IG isotypes to considering #DarkGenome protein arrays! #cancer #immunotherapy #seromics
021
Reposted by Bernard A. Fox
Dr. Lucky Tran @luckytran.com · 28/04/2025
Deaths from heart disease down 75%, that’s NIH. Deaths from stroke down 75%, that’s NIH. HIV/AIDS no longer a death sentence, that’s NIH. 99% of FDA approved drugs in the last decade, that’s NIH. Please show this video to anyone who doesn’t understand why the NIH is so important.
5650352379
Bernard A. Fox @bernardafox.bsky.social · 28/04/2025
💥🦊🎶 WORK HARD/PLAY HARD! Today at #AACR2025 was closed out by #checkpoints closing song, “Don’t Stop Believin” /it resonates with me - not only because I was born & raised in #Detroit (& NW suburbs) but because songs message - Believin we can #cure #cancer @sitcancer.bsky.social #FinishCancer
050
Reposted by Bernard A. Fox
Kieran Campbell @kieranrcampbell.bsky.social · 22/04/2025
Interested in how to infer tumour microenvironment ecosystems from scRNA-seq atlases? I'll be at #AACR25 presenting in the ED06 session this Friday 3-4.30pm. Otherwise would love to meet to chat science for anyone on here attending Preprint: www.biorxiv.org/content/10.1...
A pipeline for inferring reproducible tumour microenvironment ecosystems from scRNA-seq atlases
1194
Bernard A. Fox @bernardafox.bsky.social · 25/04/2025
Heading 2 #AACR2025 #Chicago to talk about our work on combination #cancer #immunotherapy for #HNSCC & see what is exciting scientists from across the globe. Also looking forward to visiting @loyolachicago.bsky.social Cancer Center to talk with Prof. Michael Nishimura regarding: TCR #FinishCancer
0112
Bernard A. Fox @bernardafox.bsky.social · 11/04/2025
💥 #CELL #THERAPY IN ACTION!! A Diverse & Dynamic group of the people moving the field!! #MoffittBOB #PagonaHealth @iovancebio.bsky.social #Genicity #Galapagos #avencell #Cellares #cancer #immunotherapy #CART #TIL / #Moffitt ROCKS IT with a great program! #SurgeryBranch #NCI #FinishCancer
011
Bernard A. Fox @bernardafox.bsky.social · 11/04/2025
Dr @patrickhwumd.bsky.social #Moffitt CEO opens #moffittBOB - with statement “This is where the magic will happen” - “How many lives will be saved because of what happens here today!” #FinishCancer #immunotherapy www.ubivac.com #cancer #DarkGenome #DarkMatter #AI
062
Reposted by Bernard A. Fox
Canada Healthwatch 🍁 @canadahealthwatch.ca · 21/03/2025
Measles is spreading across Canada, with 470 cases in Ontario. A look at the affected areas globalnews.ca/news/1108874... @kdangerfield.bsky.social 𝗚𝗲𝘁 𝘄𝗲𝗲𝗸𝗹𝘆 𝘂𝗽𝗱𝗮𝘁𝗲𝘀: CanadaHealthwatch.ca/newsletter 🍁
a map of Canada showing where measles is most and least active
79261
Reposted by Bernard A. Fox
Adam Kinzinger @adamkinzinger.substack.com · 21/03/2025
This is insane
3748309528942
Reposted by Bernard A. Fox
Mark Cuban @mcuban.bsky.social · 21/03/2025
This is more important than you realize. Bluesky doesn’t downgrade links. Which means news sites will get more traffic from here than other sites. Which gives them economic reasons to post here first.
485458316657
Reposted by Bernard A. Fox
Johns Hopkins Bloomberg School of Public Health @johnshopkinssph.bsky.social · 21/03/2025
Research Saves Lives. Here at the Johns Hopkins Bloomberg School of Public Health research is about more than just data-it's about people. Every future discovery starts with the work happening now. Read more about our research: hub.jhu.edu/research-sav... youtube.com/shorts/q90oY...
youtube.com
Research Saves Lives. #shorts
YouTube video by Johns Hopkins Bloomberg School of Public Health
13111
Reposted by Bernard A. Fox
Dr. Jennifer Krauel @freetailed.bsky.social · 07/03/2025
Come join us in Salem to #StandUpForScience !! 🧪
13311
Reposted by Bernard A. Fox
Wafik S. El-Deiry, MD, PhD, FACP @weldeiry.bsky.social · 23/02/2025
Promising results from @MSKCancerCenter and collaborators RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer www.nature.com/articles/s41...
nature.com
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer - Nature
In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited marked lo...
0111
Reposted by Bernard A. Fox
Center for Cancer Immunotherapy and Immunobiology @ccii-kyoto.bsky.social · 30/01/2025
"Insights from a 30-year journey: function, regulation & therapeutic modulation of PD1" Fm @natrevimmunol.bsky.social 2023: a history of the development of #antiPD1 #immunotherapy by Honjo, Chamoto et al. #Immunology #Immunosky www.nature.com/articles/s41...
nature.com
Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1 - Nature Reviews Immunology
In this Perspective, Honjo and co-workers describe the discovery of PD1 and its journey to become a major target for cancer immunotherapy. It discusses the complex regulatory systems that govern PD1 e...
0177